2m 2m 2m 2m 2m 2m 2m
AN2 THERAPEUTIC (ANTX)
NASDAQ
$3.64+$0.04 (+1.08%)
Price as of Oct 22, 2026 7:30 PM EDT- $135.9MMarket Cap
- 210.34%1-Year Change
- BiotechnologyIndustry
AN2 THERAPEUTIC (ANTX)
$3.64+$0.04 (+1.08%)
ANTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.60 | ||
Change | +$0.04 (+1.12%) | ||
Open | $3.58 | ||
High | $3.78 | ||
Low | $3.57 | ||
Previous Close | $3.56 | ||
Volume | 177,367 | ||
30-Day Average Volume | 312,520 | ||
1-Week Change | 1.69% | ||
1-Month Change | -27.42% | ||
1-Year Change | 210.34% | ||
3-Year Change | -75.98% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.7M | ||
Total Assets | $81.7M | ||
Market Cap | $135.9M | ||
Enterprise Value | $91.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.2M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$8.2M | ||
EBITDA | -$8.2M | ||
Net Working Capital | $74.4M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -20 | ||
PEG | -1 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 04/12/2018 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue